Sequence information
Variant position: 514 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 597 The length of the canonical sequence.
Location on the sequence:
VPKTIQMVRSQRSGMVQTEA
Q YRFIYMAVQHYIETLQRRIE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human VPKTIQMVRSQRSGMVQTEAQ YRFIYMAVQHYIETLQRRIE
Mouse VPKTIQMVRSQRSGMVQTEAQ YRFIYMAVQHYIETLQRRIE
Rat VPKTIQMVRSQRSGMVQTEAQ YRFIYMAVQHYIETLQRRIE
Chicken VPKTIQMVRSQRSGMVQTEAQ YRFIYMAVQHYIETLQRRIE
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
2 – 597
Tyrosine-protein phosphatase non-receptor type 11
Domain
247 – 521
Tyrosine-protein phosphatase
Binding site
510 – 510
Substrate
Alternative sequence
465 – 597
Missing. In isoform 3.
Helix
512 – 528
Literature citations
A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy.
Takahashi K.; Kogaki S.; Kurotobi S.; Nasuno S.; Ohta M.; Okabe H.; Wada K.; Sakai N.; Taniike M.; Ozono K.;
Eur. J. Pediatr. 164:497-500(2005)
Cited for: VARIANT NS1 GLU-514;
PTPN11 gene mutations: linking the Gln510Glu mutation to the 'LEOPARD syndrome phenotype'.
Digilio M.C.; Sarkozy A.; Pacileo G.; Limongelli G.; Marino B.; Dallapiccola B.;
Eur. J. Pediatr. 165:803-805(2006)
Cited for: VARIANT LPRD1 GLU-514;
Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling.
Noda S.; Takahashi A.; Hayashi T.; Tanuma S.; Hatakeyama M.;
Biochem. Biophys. Res. Commun. 469:1133-1139(2016)
Cited for: VARIANT JMML LYS-76; CHARACTERIZATION OF VARIANT JMML LYS-76; VARIANTS LPRD1 CYS-279; MET-472; PRO-510 AND GLU-514; CHARACTERIZATION OF VARIANTS LPRD1 CYS-279; MET-472; PRO-510 AND GLU-514; FUNCTION; CATALYTIC ACTIVITY; INTERACTION WITH CDC73; SUBCELLULAR LOCATION;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.